Mesothelioma or Asbestos Question?

Mesothelioma Clinical Trial Results Reported

Alfacell, the company that makes the chemotherapy drug Oncanase, has reported the results of its Phase III B clinical trial for treatment of malignant mesothelioma. According to the company, the trial did not meet their standards for overall survival.

However, the trial did have some good news. Patients who had not responded to chemotherapy treatments previously had an overall survival rate of 10.5 months. Because of this, Alfacell hopes to use Oncanase as a second line treatment in patients with inoperable mesothelioma tumors.

If you would like to know more about mesothelioma treatments, you can contact us at

One Response to “Mesothelioma Clinical Trial Results Reported”

  1. […] original here:  Mesothelioma Clinical Trial Results Reported Share and […]

Leave a Reply





Home  |  Asbestos  |  Mesothelioma  |  Treatment  |  Exposure  |  Legal  |  News  |  Articles  |  Other Law Sites  |  Log in